The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a reference collection of gene-expression profiles from cultured human cells treated with bioactive small molecules, together with pattern-matching software to mine these data. We demonstrate that this “Connectivity Map” resource can be used to find connections among small molecules sharing a mechanism of action, chemicals and physiological processes, and diseases and drugs. These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, post-perturbation transcriptomics data are particularly suited for training computational models because the causal relationship between known perturbations (cause) and the measured post-perturbation gene expression (effect) allows for the modelling of mechanistic processes [11].”
From Benchmarking foundation cell models for post-perturbation RNA-seq prediction (2025) · cites this paper as [11]
In the citing paper
“Both Alakwaa’ and Luo’s pipelines use the CLUE platform, a cloud-based platform developed by the LINCS Center for signature-gene based drug ranking61.”
From ASGARD is a single-cell guided pipeline to aid repurposing of drugs (2023) · cites this paper as [61]
In the citing paper
“For example, in a classic paradigm inflammatory bowel disease (IBD) signatures were derived from surgical specimens and intersected with Connectivity Map70 data representing transcriptional readouts across a number of cell lines in response to treatment with many hundreds of drugs using a novel pattern-matching algorithm71. From this research the anticonvulsant drug topiramate was identified and”
From Exploiting machine learning for end-to-end drug discovery and development (2019) · cites this paper as [71]
In the citing paper
“Useful tools will include maps of evolutionary conservation (108) and chromatin state (140), as well as databases of cell-state signatures, such as genome-wide expression patterns, that may integrate aspects of cell biology under resting and provoked conditions (141).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [141]
In the citing paper
“It has been shown that compounds eliciting similar transcriptional signatures tend to share mechanisms of action.170,207−209”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [207]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citationMolecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Self-citationMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationGene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale
DeRisi, J. L., Iyer, V. R., & Brown, P. O. (1997) · Science · doi:10.1126/science.278.5338.680 · Cited by 4,456
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R., Armour, C. D., Bennett, H. A., Coffey, E., Dai, H., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,533
Research works printed but not linked: 7
- K. B. Glaser et al., Mol. Cancer Ther.2, 151 (2003).
- A. E. Wakeling, M. Dukes, J. Bowler, Cancer Res.51, 3867 (1991).
- J. Y. Vanderhoek, M. B. Feinstein, Mol. Pharmacol.16, 171 (1979).
- H. Hieronymus et al. Cancer Cell in press.
- Q. Yao et al., Clin. Cancer Res.9, 4483 (2003).
- T. Kubota et al., Cancer Res.58, 3344 (1998).
- G. Wei et al. Cancer Cell in press.
Cited by
Items 801–900 of 1,037
Nanomaterials for Biosensors and Implantable Biodevices
Luz, R. A. S., Iost, R. M., & Crespilho, F. N. (2012) · Springer eBooks · doi:10.1007/978-3-642-29250-7_2 · Cited by 80
FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness
Campbell, T. M., Castro, M. A. A., de Santiago, I., Fletcher, M. N. C., Halim, S., Prathalingam, R., Ponder, B. A. J., & Meyer, K. B. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw065 · Cited by 79
Predicting protein targets for drug-like compounds using transcriptomics
Pabon, N. A., Xia, Y., Estabrooks, S. K., Ye, Z., Herbrand, A. K., Süß, E., Biondi, R. M., Assimon, V. A., Gestwicki, J. E., Brodsky, J. L., et al. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006651 · Cited by 79
Revealing Targeted Therapy for Human Cancer by Gene Module Maps
Wong, D. J., Nuyten, D. S. A., Regev, A., Lin, M., Adler, A. S., Segal, E., van de Vijver, M. J., & Chang, H. Y. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-0382 · Cited by 81
Molecular programs of fibrotic change in aging human lung
Lee, S., Islam, M. N., Boostanpour, K., Aran, D., Jin, G., Christenson, S., Matthay, M. A., Eckalbar, W. L., DePianto, D. J., Arron, J. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26603-2 · Cited by 78
Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma
Luo, Y., Shen, D., Chen, L., Wang, G., Liu, X., Qian, K., Xiao, Y., Wang, X., & Ju, L. (2019) · Aging · doi:10.18632/aging.102161 · Cited by 78
Drug repositioning with adaptive graph convolutional networks
Sun, X., Xiao, J., Lu, Z., Tang, J. P., & Li, M. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad748 · Cited by 78
Wang, K., Sun, J., Zhou, S., Wan, C., Qin, S., Li, C., He, L., & Yang, L. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003315 · Cited by 78
Zhang, H., Cohen, A. L., Krishnakumar, S., Wapnir, I., Veeriah, S., Deng, G. Y., Coram, M., Piskun, C. M., Longacre, T. A., Herrler, M., et al. (2014) · Breast Cancer Research · doi:10.1186/bcr3640 · Cited by 79
Functional genomics to uncover drug mechanism of action
Nijman, S. M. B. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1963 · Cited by 78
Cancer subtype identification using somatic mutation data
Kuijjer, M. L., Paulson, J. N., Salzman, P., Ding, W., & Quackenbush, J. F. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0109-7 · Cited by 78
Gene expression profiling in MDS and AML: potential and future avenues
Theilgaard‐Mönch, K., Boultwood, J., Ferrari, S., Giannopoulos, K., Hernández‐Rivas, J. M., Kohlmann, A., Morgan, M. A., Porse, B. T., Tagliafico, E., Zwaan, C. M., et al. (2011) · Leukemia · doi:10.1038/leu.2011.48 · Cited by 78
Monks, A. P., Zhao, Y., Hose, C. D., Hamed, H. A., Krushkal, J., Fang, J., Sonkin, D., Palmisano, A., Polley, E. C., Fogli, L. K., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0989 · Cited by 78
Huang, L. F., Injac, S. G., Cui, K., Braun, F., Qi, L., Du, Y., Zhang, H., Kogiso, M., Lindsay, H., Zhao, S., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat0150 · Cited by 77
HSP90 inhibitor geldanamycin reverts IL-13– and IL-17–induced airway goblet cell metaplasia
Pezzulo, A. A., Tudas, R. A., Stewart, C. G., Buonfiglio, L. G. V., Lindsay, B. D., Taft, P. J., Gansemer, N. D., & Zabner, J. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123524 · Cited by 77
Connecting chemistry and biology through molecular descriptors
Fernández-Torras, A., Comajuncosa-Creus, A., Duran-Frigola, M., & Aloy, P. (2022) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.09.001 · Cited by 68
The era of high-quality chemical probes
Licciardello, M. P., & Workman, P. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00291d · Cited by 77
Gene Expression Signature-Based Screening Identifies New Broadly Effective Influenza A Antivirals
Josset, L., Textoris, J., Loriod, B., Ferraris, O., Moulés, V., Lina, B., Nguyen, C., Diaz, J., & Rosa‐Calatrava, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013169 · Cited by 77
Pharmacogenetics in Acute Lymphoblastic Leukemia
Cheok, M. H.-C., Pottier, N., Kager, L., & Evans, W. E. (2008) · Seminars in Hematology · doi:10.1053/j.seminhematol.2008.09.002 · Cited by 77
Glioblastoma: Imaging Genomic Mapping Reveals Sex-specific Oncogenic Associations of Cell Death
Colen, R. R., Wang, J., Singh, S. K., Gutman, D. A., & Zinn, P. O. (2014) · Radiology · doi:10.1148/radiol.14141800 · Cited by 78
Modulating cancer cell survival by targeting intracellular cholesterol transport
Kuzu, O. F., Gowda, R., Noory, M. A., & Robertson, G. P. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.200 · Cited by 78
Gene expression‐based drug repurposing to target aging
Dönertaş, H. M., Fuentealba Valenzuela, M., Partridge, L., & Thornton, J. M. (2018) · Aging Cell · doi:10.1111/acel.12819 · Cited by 73
Nymark, P. E. H., Bakker, M. I., Dekkers, S., Franken, R., Fransman, W., García‐Bilbao, A., Greco, D., Gulumian, M., Hadrup, N., Halappanavar, S. S., et al. (2020) · Small · doi:10.1002/smll.201904749 · Cited by 77
Linking Phenotypes and Modes of Action Through High-Content Screen Fingerprints
Reisen, F., Sauty de Chalon, A., Pfeifer, M., Zhang, X., Gabriel, D., & Selzer, P. (2015) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2015.656 · Cited by 76
Target-Based Drug Repositioning Using Large-Scale Chemical–Protein Interactome Data
Sawada, R., Iwata, H., Mizutani, S., & Yamanishi, Y. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00330 · Cited by 69
An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines
Dutil, J., Chen, Z., Monteiro, Á. N. A., Teer, J. K., & Eschrich, S. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2747 · Cited by 77
Robertson, A. G., Meghani, K. A., Cooley, L. F., McLaughlin, K. A., Fall, L. A., Yu, Y., Castro, M. A. A., Groeneveld, C. S., de Reyniès, A., Nazarov, V. I., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37568-9 · Cited by 76
A Survey on the Computational Approaches to Identify Drug Targets in the Postgenomic Era
Dai, Y.-F., & Zhao, X.-M. (2015) · BioMed Research International · doi:10.1155/2015/239654 · Cited by 76
Huang, T., Cui, W., Hu, L., Feng, K., Li, Y., & Cai, Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008126 · Cited by 76
Fu, X., Creighton, C. J., Biswal, N. C., Kumar, V., Shea, M. J., Herrera, S., Contreras, A., Gutiérrez, C., Wang, T., Nanda, S., et al. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0430-x · Cited by 77
A chemical–genetic interaction map of small molecules using high‐throughput imaging in cancer cells
Breinig, M., Klein, F. A., Huber, W., & Boutros, M. (2015) · Molecular Systems Biology · doi:10.15252/msb.20156400 · Cited by 71
DBTSS/DBKERO for integrated analysis of transcriptional regulation
Suzuki, A., Kawano, S., Mitsuyama, T., Suyama, M., Kanai, Y., Shirahige, K., Sasaki, H., Tokunaga, K., Tsuchihara, K., Sugano, S., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1001 · Cited by 76
SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines
Demichelis, F., Greulich, H., Macoska, J. A., Beroukhim, R., Sellers, W. R., Garraway, L., & Rubin, M. A. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn089 · Cited by 76
Mishra, R. R., Belder, N., Ansari, S. A., Kayhan, M., Bal, H., Raza, U., Ersan, P. G., Tokat, Ü. M., Eyüpoğlu, E., Saatci, Ö., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2776 · Cited by 76
Song, F., Wang, C., Mao, J., Wang, T., Liang, X., Hu, C.-W., Zhang, Y., Han, L., & Zhong, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1197152 · Cited by 75
Lesterhuis, W. J., Rinaldi, C., Jones, A. C., Rozali, E. N., Dick, I. M., Khong, A., Boon, L., Robinson, B. W. S., Nowak, A. K., Bosco, A., et al. (2015) · Scientific Reports · doi:10.1038/srep12298 · Cited by 75
A gene transcription signature of obesity in breast cancer
Creighton, C. J., Sada, Y. H., Zhang, Y., Tsimelzon, A. I., Wong, H. H., Dave, B., Landis, M. D., Bear, H. D., Rodriguez, A. A., & Chang, J. C. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1595-y · Cited by 75
Network based elucidation of drug response: from modulators to targets
Iorio, F., Saez-Rodriguez, J., & Bernardo, D. D. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-139 · Cited by 64
Molecular classification of solid tumours: towards pathway-driven therapeutics
Swanton, C., & Caldas, C. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605031 · Cited by 75
Androgen receptor as potential therapeutic target in metastatic endometrial cancer
Tangen, I. L., Onyango, T. B., Kopperud, R., Berg, A., Halle, M. K., Øyan, A. M., Werner, H. M. J., Trovik, J., Kalland, K. H., Salvesen, H. B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10334 · Cited by 68
van der Zande, M., Undas, A. K., Kramer, E., Monopoli, M. P., Peters, R., Garry, D., Fernandes, E. C. A., Hendriksen, P. J. M., Marvin, H. J. P., Peijnenburg, A., et al. (2016) · Nanotoxicology · doi:10.1080/17435390.2016.1225132 · Cited by 75
Hypoxia-Induced Downregulation of DUSP-2 Phosphatase Drives Colon Cancer Stemness
Hou, P.-C., Li, Y.-H., Lin, S.-C., Lin, S.-C., Lee, J.-C., Lin, B.-W., Liou, J.-P., Chang, J.-Y., Kuo, C.-C., Liu, Y.-M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2990 · Cited by 69
A Pipeline for High-Throughput Concentration Response Modeling of Gene Expression for Toxicogenomics
House, J. S., Grimm, F. A., Jima, D. D., Zhou, Y.-H., Rusyn, I., & Wright, F. A. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00168 · Cited by 69
Additive dose response models: defining synergy
Lederer, S., Dijkstra, T. M. H., & Heskes, T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01384 · Cited by 74
“We further looked up the seven dose combinations (excluding the one where the compound is combined with itself) in the Connectivity Map [Subramanian et al., 2017, Lamb et al., 2006].”
BackgroundPredicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways
Yu, L., Wang, M., Yang, Y., Xu, F., Zhang, X., Xie, F., Gao, L., & Li, X. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008696 · Cited by 74
Jiang, S., Ren, X., Liu, S., Lü, Z., Xu, A., Qin, C., & Wang, Z. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.627508 · Cited by 74
Cell-type-directed network-correcting combination therapy for Alzheimer’s disease
Li, Y., Serras, C. P., Blumenfeld, J. R., Xie, M., Hao, Y., Deng, E., Chun, Y. Y., Holtzman, J., An, A., Yoon, S. Y., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.035 · Cited by 74
Exploring genomic profiles of hepatocellular carcinoma
Woo, H. G., Park, E. S., Thorgeirsson, S. S., & Kim, Y. J. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20691 · Cited by 74
Qu, X. A., Gudivada, R. C., Jegga, A. G., Neumann, E., & Aronow, B. J. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-s5-s4 · Cited by 74
Jia, Z., Liu, Y., Guan, N., Bo, X., Luo, Z., & Barnes, M. R. (2016) · BMC Genomics · doi:10.1186/s12864-016-2737-8 · Cited by 74
Wang, Z., Arat, S., Magid-Slav, M., & Brown, J. R. (2018) · BMC Systems Biology · doi:10.1186/s12918-017-0524-z · Cited by 74
Cheminformatics Tools for Analyzing and Designing Optimized Small Molecule Collections and Libraries
Moret, N., Clark, N. A., Hafner, M. A., Wang, Y., Lounkine, E., Medvedovic, M., Wang, J., Gray, N. S., Jenkins, J. L., & Sorger, P. K. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2019.02.018 · Cited by 74
Case study: the role of mechanistic network models in systems toxicology
Hoeng, J., Talikka, M., Martin, F. P., Sewer, A., Yang, X., Iskandar, A. R., Schlage, W. K., & Peitsch, M. C. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.023 · Cited by 73
DeSigN: connecting gene expression with therapeutics for drug repurposing and development
Lee, B. K. B., Tiong, K. H., Chang, J. K., Liew, C. S., Rahman, Z. A. A., Tan, A. C., Khang, T. F., & Cheong, S. C. (2017) · BMC Genomics · doi:10.1186/s12864-016-3260-7 · Cited by 73
Drug Repurposing Using Deep Embeddings of Gene Expression Profiles
Donner, Y., Kazmierczak, S., & Fortney, K. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00284 · Cited by 73
Artificial intelligence in the early stages of drug discovery
Cavasotto, C. N., & Di Filippo, J. I. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108730 · Cited by 65
Systems pharmacology approaches in herbal medicine research: a brief review
Lee, M., Shin, H., Park, M., Kim, A., Cha, S., & Lee, H. (2022) · BMB Reports · doi:10.5483/bmbrep.2022.55.9.102 · Cited by 76
Coombs, G. S., Schmitt, A. A., Canning, C. A., Alok, A., Low, I. C. C., Banerjee, N., Kaur, S., Utomo, V, Jones, C. M., Pervaiz, S., et al. (2012) · Oncogene · doi:10.1038/onc.2011.228 · Cited by 68
CDA: Combinatorial Drug Discovery Using Transcriptional Response Modules
Lee, J. H., Kim, D. G., Bae, T., Rho, K., Kim, J. T., Lee, J.-J., Jang, Y., Kim, B. C., Park, K. M., & Kim, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042573 · Cited by 73
Genomics and transcriptomics in drug discovery
Dopazo, J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.06.003 · Cited by 74
A review of validation strategies for computational drug repositioning
Brown, A. S., & Patel, C. J. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bbw110 · Cited by 68
Soo, H. C., Chung, F. F., Lim, K., Yap, V. A., Bradshaw, T. D., Hii, L., Tan, S.-H., See, S.-J., Tan, Y.-F., Leong, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170551 · Cited by 73
Teng, H., Mao, F., Liang, J., Xue, M., Wei, W., Li, X., Zhang, K., Feng, D., Liu, B., & Sun, Z. S. (2018) · Theranostics · doi:10.7150/thno.26862 · Cited by 73
Machine learning prediction of oncology drug targets based on protein and network properties
Dezső, Z., & Ceccarelli, M. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3442-9 · Cited by 64
Personalized Medicine for High Blood Pressure
Turner, S. T., Schwartz, G. L., & Boerwinkle, E. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.087049 · Cited by 73
Ashton, J. M., Balys, M., Neering, S. J., Hassane, D. C., Cowley, G., Root, D. E., Miller, P. G., Ebert, B. L., McMurray, H. R., Land, H., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.024 · Cited by 68
Karczewski, K. J., Daneshjou, R., & Altman, R. B. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002817 · Cited by 65
Li, C., Hsiang, C., Wu, S., & Ho, T. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.02.025 · Cited by 72
Neuroprotective activity and evaluation of Hsp90 inhibitors in an immortalized neuronal cell line
Lu, Y., Ansar, S., Michaelis, M. L., & Blagg, B. S. J. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.12.047 · Cited by 72
Reka, A. K., Kuick, R. D., Kurapati, H., Standiford, T. J., Omenn, G. S., & Keshamouni, V. G. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31822adfb0 · Cited by 72
Petrich, A. M., Leshchenko, V. V., Kuo, P.-Y., Xia, B., Thirukonda, V. K., Ulahannan, N., Gordon, S. A. K., Fazzari, M. J., Ye, B. H., Sparano, J. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1407 · Cited by 72
Grouping 34 Chemicals Based on Mode of Action Using Connectivity Mapping
De Abrew, K. N., Kainkaryam, R. M., Shan, Y. K., Overmann, G. J., Settivari, R. S., Wang, X., Xu, J., Adams, R. L., Tiesman, J. P., Carney, E. W., et al. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw058 · Cited by 70
Malcomson, B., Wilson, H., Veglia, E., Thillaiyampalam, G., Barsden, R., Donegan, S., Elbanna, A., Elborn, J. S., Ennis, M., Kelly, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520289113 · Cited by 72
Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases
Wooden, B., Goossens, N., Hoshida, Y., & Friedman, S. L. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.065 · Cited by 69
Lv, C., Zeng, H., Wang, J., Yuan, X., Zhang, C., Fang, T., Yang, P., Wu, T., Zhou, Y., Nagle, D. G., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0247-5 · Cited by 73
Pizzorno, A., Terrier, O., de Lamballerie, C. N., Julien, T., Padey, B., Traversier, A., Roche, M., Hamelin, M., Rhéaume, C., Croze, S., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00060 · Cited by 72
Tarkhov, A. E., Alla, R., Ayyadevara, S., Pyatnitskiy, M., Menshikov, L. I., Shmookler Reis, R. J., & Fedichev, P. O. (2019) · Scientific Reports · doi:10.1038/s41598-019-43075-z · Cited by 65
Cichonska, A., Rousu, J., & Aittokallio, T. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1096926 · Cited by 65
Kang, B. H., Tavecchio, M., Goel, H. L., Hsieh, C.-C., Garlick, D. S., Raskett, C. M., Lian, J. B., Stein, G. S., Languino, L. R., & Altieri, D. C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.9 · Cited by 71
Laenen, G., Thorrez, L., Börnigen, D., & Moreau, Y. (2013) · Molecular BioSystems · doi:10.1039/c3mb25438k · Cited by 71
Vilar, E., Mukherjee, B., Kuick, R., Raskin, L., Misek, D. E., Taylor, J. M. G., Giordano, T. J., Hanash, S. M., Fearon, E. R., Rennert, G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2432 · Cited by 66
Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands
Wood, T. E., Dalili, S., Simpson, C. D., Sukhai, M. A., Hurren, R., Anyiwe, K., Mao, X., Suárez, F., Gronda, M., Eberhard, Y., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0495 · Cited by 71
Global cellular response to chemotherapy-induced apoptosis
Wiita, A. P., Ziv, E., Wiita, P. J., Urisman, A., Julien, O., Burlingame, A. L., Weissman, J. S., & Wells, J. A. (2013) · eLife · doi:10.7554/elife.01236 · Cited by 71
Comess, K. M., McLoughlin, S. M., Oyer, J. A., Richardson, P. L., Stöckmann, H., Vasudevan, A., & Warder, S. E. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01921 · Cited by 73
Identification of target genes in cardiomyopathy with fibrosis and cardiac remodeling
Zhao, J., Lv, T., Quan, J., Zhao, W., Song, J., Li, Z., Lei, H., Huang, W., & Ran, L. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0459-8 · Cited by 71
Pavlinov, I., Gerlach, E. M., & Aldrich, L. N. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob02327a · Cited by 71
Signature-based approaches for informed drug repurposing: targeting CNS disorders
Shukla, R., Henkel, N., Alganem, K., Hamoud, A.-R. A., Reigle, J. K., Alnafisah, R. S., Eby, H., Imami, A. S., Creeden, J. F., Miruzzi, S. A., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0752-6 · Cited by 72
Systems Pharmacology Meets Predictive, Preventive, Personalized and Participatory Medicine
Jenkins, S. L., & Ma’ayan, A. (2013) · Pharmacogenomics · doi:10.2217/pgs.12.186 · Cited by 71
Bhat‐Nakshatri, P., Goswami, C. P., Badve, S., Sledge, G. W., & Nakshatri, H. (2013) · Scientific Reports · doi:10.1038/srep02530 · Cited by 70
A network model for angiogenesis in ovarian cancer
Glass, K., Quackenbush, J. F., Spentzos, D., Haibe‐Kains, B., & Yuan, G. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0551-y · Cited by 70
Yeung, T.-L., Sheng, J., Leung, C. S., Li, F., Kim, J., Ho, S., Matzuk, M. M., Lu, K. H., Wong, S. T. C., & Mok, S. C. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy097 · Cited by 70
Xu, Y., Au, N. P. B., & Ma, C. H. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.896852 · Cited by 70
Shigemizu, D., Hu, Z., Hung, J., Huang, C. L., Wang, Y., & DeLisi, C. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002347 · Cited by 70
Repurpose terbutaline sulfate for amyotrophic lateral sclerosis using electronic medical records
Paik, H., Chung, A.-Y., Park, H.-C., Park, R. W., Suk, K., Kim, J., Kim, H., Lee, K., & Butte, A. J. (2015) · Scientific Reports · doi:10.1038/srep08580 · Cited by 59
Evaluating Therapeutic Efficacy against Cancer Stem Cells: New Challenges Posed by a New Paradigm
Wang, J. C. Y. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.10.005 · Cited by 70
Muthuswami, M., Ramesh, V., Banerjee, S., Thangaraj, S. V., Periasamy, J., Rao, D. B., Barnabas, G. D., Raghavan, S., & Ganesan, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077553 · Cited by 70
Sanda, T., Li, X., Gutiérrez, A., Ahn, Y., Neuberg, D. S., O’Neil, J., Strack, P. R., Winter, C. G., Winter, S. S., Larson, R. A., et al. (2009) · Blood · doi:10.1182/blood-2009-07-235143 · Cited by 70
Lee, S., Lee, K. H., Song, M., & Lee, D. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-s2-s2 · Cited by 71
Network biology methods integrating biological data for translational science
Bebek, G., Koyuturk, M., Price, N. D., & Chance, M. R. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbr075 · Cited by 63
Computational Repositioning and Preclinical Validation of Pentamidine for Renal Cell Cancer
Zerbini, L. F., Bhasin, M., de Vasconcellos, J. F., Paccez, J. D., Gu, X., Kung, A. L., & Libermann, T. A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0750 · Cited by 70
Metadata
- Authors
- Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., Reich, M., Hieronymus, H., Wei, G., Armstrong, S. A., Haggarty, S. J., Clemons, P. A., Wei, R., Carr, S. A., Lander, E. S., & Golub, T. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Lamb, Justin
- Crawford, Emily D.
- Golub, Todd R.
- ORCID
- Venue
- Science
- Published
- 2006-09-29
- Volume
- 313
- Issue
- 5795
- Pages
- 1929-1935
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2121604817
- Cited by
- 5,257
- References
- 41
- Citations by year
- 2026: 226 · 2025: 285 · 2024: 332 · 2023: 370 · 2022: 416 · 2021: 406 · 2020: 383 · 2019: 385 · 2018: 280 · 2017: 288 · 2016: 296 · 2015: 259 · 2014: 217 · 2013: 241 · 2012: 219
- FWCI
- 118.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Connectivity Map, gene expression signatures, small molecules, drug action, gene perturbation, mechanism of action, cultured human cells, functional genomics
- MeSH terms
- Alzheimer Disease, Cell Line, Dexamethasone, Drug Evaluation, Preclinical, Enzyme Inhibitors, Estrogens, Humans, Obesity, Phenothiazines, Software, Gene Expression, Databases, Factual, HSP90 Heat-Shock Proteins, Drug Resistance, Neoplasm, Sirolimus, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Limonins, Cell Line, Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.